Kowalczyk L. 2004, August 1. Colonoscopies tax health industry. The Boston Globe A-1.
Ladabaum U, Song K, Fendrick AM. 2004. Colorectal neoplasia screening with virtual colonoscopy: When, at what cost, and with what national impact? Clinical Gastroenterology & Hepatology 2(7):554–563.
Lieberman DA. 1995. Cost-effectiveness model for colon cancer screening. Gastroenterol 109(6): 1781–90.
Lieberman DA, Prindiville S, Weiss DG, Willett W. 2003. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 290(22):2959–2967.
Lieberman DA, Prindiville S, Weiss DG, Willett W, Imperiale T. 2004. Risk factors for advanced colonic neoplasia: From evidence to application. Evidence-Based Gastroenterology 5(3):86–87.
Loeve F, Boer R, Van Oortmarssen GJ, Van Ballegooijen M, Habbema JDF. 1999. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res 32(1):13–33.
Loeve F, Brown ML, Boer R, Van Ballegooijen M, Van Oortmarssen GJ, Habbema JDF. 2000. Endoscopic colorectal cancer screening: A cost-saving analysis. J Natl Cancer Inst 92(7): 557–563.
Mandel JS, Church TR, Ederer F, Bond JH. 1999. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91(5):434–437.
Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. 2004. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 141(4).
Neilson AR, Whynes DK. 1995. Cost-effectiveness of screening for colorectal cancer: A simulation model. IMA J Math Appl Med Biol 12(3–4):355–367.
Ness RM, Holmes AM, Klein R, Dittus R. 2000. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol 95(7):1800–1811.
Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, Wong RK, Nugent PA, Mysliwiec PA, Schindler WR. 2003. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349(23):2191–2200.
Pignone M, Saha S, Hoerger T, Mandelblatt J. 2002. Cost-effectiveness analyses of colorectal cancer screening: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137(2):96–104.
Ransohoff DF. 2004. Virtual colonoscopy: What it can do vs what it will do. JAMA 291(14): 1772–1774.
Schoen RE, Pinsky PF, Weissfeld JL, Bresalier RS, Church T, Prorok P, Gohagan JK. 2003. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 290(1):41–48.
Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. 2002. Effect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. Gut 50(6):840–844.
Smith RA, Cokkinides V, Eyre HJ. 2004. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 54(1):41–52.
Song K, Fendrick AM, Ladabaum U. 2004. Fecal DNA testing compared with conventional colorectal cancer screening methods: A decision analysis. Gastroenterol 126(5):1270–1279.
Sonnenberg A, Delco F. 2002. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med 162(2):163–168.
Sonnenberg A, Delco F, Inadomi JM. 2000. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133(8):573–584.
Theuer CP, Wagner JL, Taylor TH, Brewster WR, Tran D, McLaren CE, Anton-Culver H. 2001. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterol 120(4):848–856.
Trochim WM. 2004. The Research Methods Knowledge Base. 2nd ed. [online] http://www.socialresearchmethods.net/kb/index.htm.
United States General Accounting Office. 2004. Coverage of Common Colorectal Cancer Screening Tests Is Common. Washington DC: United States General Accounting Office.